{
    "eid": "2-s2.0-85095823833",
    "title": "Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen\u00ae) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen\u00ae) vaccine for immunization of adolescents and adults in Thailand",
    "cover-date": "2020-12-03",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Booster",
        "Pertussis",
        "Pharmacovigilance",
        "Post-licensure",
        "Pregnancy",
        "Recombinant",
        "Safety"
    ],
    "authors": [
        "Librada Fortuna",
        "Surasith Chaithongwongwatthana",
        "Ngamphol Soonthornworasiri",
        "Jane Spiegel",
        "Wassana Wijagkanalan",
        "Souad Mansouri",
        "Anita H.J. van den Biggelaar",
        "Hong Thai Pham"
    ],
    "citedby-count": 7,
    "ref-count": 50,
    "ref-list": [
        "Epidemic pertussis in 2012 \u2013 the resurgence of a vaccine-preventable disease",
        "An update of the global burden of pertussis in children younger than 5 years: a modelling study",
        "Severe underestimation of pertussis related hospitalizations and deaths in the Netherlands: a capture-recapture analysis",
        "Number and order of whole cell pertussis vaccines in infancy and disease protection",
        "Waning immunity to pertussis following 5 doses of DTaP",
        "Waning Tdap effectiveness in adolescents",
        "The impact of past vaccination coverage and immunity on pertussis resurgence",
        "Pertussis vaccines: WHO position paper - September 2015",
        "Recommendations to control pertussis prioritized relative to economies: a Global Pertussis Initiative update",
        "Pertussis in the Association of Southeast Asian Nations: epidemiology and challenges",
        "Seroprevalence of antibodies to pertussis toxin among different age groups in Thailand after 37 years of universal whole-cell pertussis vaccination",
        "Pertussis surveillance in a children hospital in Bangkok",
        "Adult pertussis is unrecognized public health problem in Thailand",
        "Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange",
        "A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial",
        "Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial",
        "Boosting teenagers with acellular pertussis vaccines containing recombinant or chemically inactivated pertussis toxin: a randomized clinical trial",
        "Guide to active vaccine safety surveillance: report of CIOMS working group on vaccine safety \u2013 executive summary",
        "Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults",
        "Obstetrical and neonatal case definitions for immunization safety data",
        "A 6-year prospective, observational, multi-center post-marketing surveillance of the safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in Korea",
        "Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial",
        "Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women",
        "A cohort study of the association between maternal serum Inhibin-A and adverse pregnancy outcomes: a population-based study",
        "Establishing of national birth defects registry in Thailand",
        "Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women",
        "Effectiveness of maternal pertussis vaccination in England: an observational study",
        "Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction",
        "Impact of the US maternal tetanus, diphtheria, and acellular pertussis vaccination program on preventing pertussis in infants <2 months of age: a case-control evaluation",
        "Maternal vaccination in Argentina: Tdap vaccine effectiveness during pregnancy in preventing pertussis in infants less than 2 months of age",
        "Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study",
        "Incidence of tetanus and diphtheria in relation to adult vaccination schedules",
        "Diphtheria, tetanus, and pertussis: unequal vaccine siblings with distinct characteristics",
        "Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations",
        "Global perspectives on immunization during pregnancy and priorities for future research and development: an international consensus statement",
        "Genetically modified pertussis toxin: a quantum leap?",
        "Acellular pertussis vaccines: where to go to?",
        "The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies",
        "Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "111805699",
            "affilname": "BioNet-Asia Co.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/111805699",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}